299 related articles for article (PubMed ID: 10431429)
1. Outcomes from treatment. Clinical applications from recent trials.
Howes LG
Aust Fam Physician; 1999 Jul; 28(7):707-10. PubMed ID: 10431429
[TBL] [Abstract][Full Text] [Related]
2. ESH-ESC guidelines for the management of hypertension.
Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
[TBL] [Abstract][Full Text] [Related]
3. [Success of blood pressure reduction in diabetic patients].
Schernthaner G
Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S247-51. PubMed ID: 17139580
[TBL] [Abstract][Full Text] [Related]
4. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
Oparil S; Bakir SE
Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
[TBL] [Abstract][Full Text] [Related]
5. Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trial: the first randomized controlled trial to compare the clinical outcome effects of first-line combination therapies in hypertension.
Jamerson KA; Bakris GL; Wun CC; Dahlöf B; Lefkowitz M; Manfreda S; Pitt B; Velazquez EJ; Weber MA
Am J Hypertens; 2004 Sep; 17(9):793-801. PubMed ID: 15363822
[TBL] [Abstract][Full Text] [Related]
6. The future of antihypertensive treatment.
Israili ZH; Hernández-Hernández R; Valasco M
Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
[TBL] [Abstract][Full Text] [Related]
7. Redefining efficacy of antihypertensive therapies beyond blood pressure reduction--the role of angiotensin II antagonists.
Conlin PR
Int J Clin Pract; 2005 Feb; 59(2):214-24. PubMed ID: 15854200
[TBL] [Abstract][Full Text] [Related]
8. Diuretics for cardiovascular prevention in the elderly.
Hanon O; Seux ML; Lenoir H; Rigaud AS; Girerd X; Forette F
J Hum Hypertens; 2004 Dec; 18 Suppl 2():S15-22. PubMed ID: 15592568
[TBL] [Abstract][Full Text] [Related]
9. Choice of antihypertensive drug in the diabetic patient.
Ong HT; Cheah JS
MedGenMed; 2005 May; 7(2):74. PubMed ID: 16369452
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
11. Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.
Leenen FH
Can J Cardiol; 2004 Aug; 20 Suppl B():77B-82B. PubMed ID: 15309209
[TBL] [Abstract][Full Text] [Related]
12. Long-term safety of antihypertensive therapy.
Grossman E; Messerli FH
Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
[TBL] [Abstract][Full Text] [Related]
13. Implications of the ADVANCE study for clinical practice.
Zannad F
J Hypertens Suppl; 2008 Sep; 26(3):S29-32. PubMed ID: 19363850
[TBL] [Abstract][Full Text] [Related]
14. A review of renal, cardiovascular and mortality endpoints in antihypertensive trials in diabetic patients.
García-Donaire JA; Segura J; Cerezo C; Ruilope LM
Blood Press; 2011 Dec; 20(6):322-34. PubMed ID: 21936729
[TBL] [Abstract][Full Text] [Related]
15. [Antihypertensive therapy in the elderly: results of large trials].
Leonetti G; Cuspidi C; Facchini M
Ital Heart J Suppl; 2001 Nov; 2(11):1161-9. PubMed ID: 11775407
[TBL] [Abstract][Full Text] [Related]
16. [Spanish contribution to the HOT (Hypertension Optimal Treatment) study. Final results. Spanish Investigators in the HOT study].
Suárez C; Cucala M; Coca A; Ruilope LM
Med Clin (Barc); 1999 Oct; 113(10):361-5. PubMed ID: 10562937
[TBL] [Abstract][Full Text] [Related]
17. Hypertension in the elderly: new and old evidence that treatment may benefit the old.
Fagard RH
J Nephrol; 2009; 22(5):580-6. PubMed ID: 19809990
[TBL] [Abstract][Full Text] [Related]
18. Treatment of isolated systolic hypertension in diabetes mellitus type 2.
Os I; Gudmundsdottir H; Kjeldsen SE; Oparil S
Diabetes Obes Metab; 2006 Jul; 8(4):381-7. PubMed ID: 16776744
[TBL] [Abstract][Full Text] [Related]
19. [Are all antihypertensive drugs renoprotective?].
Wolf S; Risler T
Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
[TBL] [Abstract][Full Text] [Related]
20. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
